跳至主要内容
临床试验/IRCT20221220056874N1
IRCT20221220056874N1尚未招募3 期

Evaluation of effect of Teriparatide in the acceleration of comminuted fracture union of tibia and femural shaft

Karaj University of Medical Sciences0 个研究点目标入组 52 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
52

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 45 years(—)
性别
All

入选标准

  • Having comminuted fractured tibia and femural shaft
  • Obtaining informed consent to participate in this study
  • Being between 18-45 years old
  • Not having osteoporosis that has been confirmed in the radiographies
  • Not being allergic to triparatide
  • If a person has previously used bisphosphonates, at least three months should pass after stopping their use, and then start triparatide.
  • Not having a serious underlying disease such as uncontrolled diabetes, heart failure, kidney failure, etc.
  • Not having Paget's disease, hypercalcemia for any reason, hyperparathyroidism
  • No history of osteosarcoma

排除标准

  • Under 18 and over 45 years old
  • Allergy to triparatide
  • Having a serious underlying disease such as uncontrolled diabetes, heart failure, kidney failure, etc.
  • Having Paget's disease, hypercalcemia for any reason, hyperparathyroidism
  • Having a history of osteosarcoma

研究者

发起方
Karaj University of Medical Sciences

相似试验

进行中(未招募)
不适用
Comparison of the Effects of Teriparatide with those of Risendronate on Lumbar Spine Volumetric Bone Mineral Density in GLucocorticpid-Induced Osteoporosis in Men - GHDH
EUCTR2006-006315-68-DEEli Lilly and Company Limited104
进行中(未招募)
不适用
Comparison of the Effects of Teriparatide with those of Risedronate on Lumbar Spine Volumetric Bone Mineral Density in Glucocorticoid-Induced Osteoporosis in Men - ND
EUCTR2006-006315-68-ITEli Lilly and Company104
进行中(未招募)
1 期
Comparison of the Effects of Teriparatide with those of Risedronate on Lumbar Spine Bone Mineral Density in Men and Postmenopausal Women with Low Bone Mass and a Recent Pertrochanteric Hip Fracture
EUCTR2008-002693-35-GBEli Lilly and Company Ltd171
进行中(未招募)
1 期
Comparison of Teriparatide with Risedronate on Lumbar Spine Bone Mineral Density in Men and Postmenopausal Women with Low Bone Mass and a Recent Pertrochanteric Hip FracturePostmenopausal Women and Men with Low Bone Mass and a Recent Pertrochanteric FractureMedDRA version: 17.1Level: LLTClassification code 10031288Term: Osteoporosis with fractureSystem Organ Class: 100000004859
EUCTR2008-002693-35-SEEli Lilly and Company Ltd285
进行中(未招募)
1 期
Comparison of the Effects of Teriparatide with those of Risedronate on Lumbar Spine Bone Mineral Density in Men and Postmenopausal Women with Low Bone Mass and a Recent Pertrochanteric Hip Fracture - GHDKPostmenopausal Women and Men with Low Bone Mass and a Recent Pertrochanteric FractureMedDRA version: 9.1Level: LLTClassification code 10031282Term: Osteoporosis
EUCTR2008-002693-35-NOEli Lilly and Company Ltd171